787 results on '"Dunn, Ben M."'
Search Results
202. Preface
203. Engineered Enzymes
204. Preparation and Handling of Peptides
205. Conventional Chromatographic Separations
206. Detection and Assay Methods
207. A long day's journey towards insight
208. Computational Analysis
209. Post‐Translational Modification: Specialized Applications
210. Methemoglobinemia after topical anesthesia with lidocaine and benzocaine for a difficult intubation
211. PROTEASES OF INFECTIOUS AGENTS
212. Mycobacterium tuberculosis Hip1 Modulates Macrophage Responses through Proteolysis of GroEL2.
213. Editorial
214. Retroviral proteases
215. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: Structure-based drug design and the resistance problem
216. Active site specificity of plasmepsin II
217. The promiscuous active site specificity /binding preferences of the fungal aspartic proteinase, rhizopuspepsin
218. Toward a universal inhibitor of retroviral proteases: Comparative analysis of the interactions of LP‐130 complexed with proteases from HIV‐1, FIV, and EIAV
219. Prime region subsite specificity characterization of human cathepsin D: The dominant role of position 128
220. Plasmodium falciparum, P. vivax,andP. malariae:A Comparison of the Active Site Properties of Plasmepsins Cloned and Expressed from Three Different Species of the Malaria Parasite
221. Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition
222. Expression and Characterisation of Plasmepsin I from Plasmodium falciparum
223. Expression, Characterisation and Mutagenesis of the Aspartic Proteinase from Equine Infectious Anaemia Virus
224. Self-activation of Recombinant Human Lysosomal Procathepsin D at a Newly Engineered Cleavage Junction, “Short” Pseudocathepsin D
225. Natural Variation in HIV-1 Protease, Gag p7 and p6, and Protease Cleavage Sites within Gag/Pol Polyproteins: Amino Acid Substitutions in the Absence of Protease Inhibitors in Mothers and Children Infected by Human Immunodeficiency Virus Type 1
226. 41 - Human immunodeficiency virus 1 retropepsin
227. 51 - Feline immunodeficiency virus retropepsin
228. 42 - Human immunodeficiency virus 2 retropepsin
229. 25 - Rhizopuspepsin
230. Editorial
231. Monomeric human cathepsin E
232. Exploring the binding preferences/specificity in the active site of human cathepsin E
233. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus
234. High level expression and characterisation of Plasmepsin II, an aspartic proteinase fromPlasmodium falciparum
235. Aspartic proteinases from the human malarial parasite Plasmodium falciparum
236. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum
237. Redesign of the substrate specificity of human cathepsin D: the dominant role of position 287 in the S2 subsite
238. Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation
239. Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling
240. Intrinsic activity of precursor forms of HIV‐1 proteinase
241. Comparison of Alkyl-Bonded Alumina Stationary Phases for Peptide Separations by High Performance Liquid Chromatography
242. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic-hydrophobic- or -aromatic-Pro- cleavage sites
243. Substrate specificity and kinetic properties of pepstatin-insensitive carboxyl proteinase from Pseudomanas sp. No. 101
244. Inhibitor-Induced ConformationalShifts and Ligand-ExchangeDynamics for HIV-1 Protease Measured by Pulsed EPR and NMRSpectroscopy.
245. Design of Novel Synthetic Peptides Including Cyclic Conformationally and Topgraphically Constrained Analogs.
246. Solid-Phase Synthesis of Phosphorylated Tyr-Peptides by "Phosphite Triester" Phosphorylation.
247. Synthesis of Phosphopeptides Containing O-Phosphoserine and O-Phosphothreonine.
248. Site-Specific Chemical Modification Procedures.
249. Formation of Disulfide Bonds in Synthetic Peptides and Proteins.
250. Bromoacetylated Synthetic Peptides.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.